Diagnosis
Women in UK with PCOS facing widespread failures in treatment, report finds

Women with polycystic ovarian syndrome face long waits for diagnosis and poor access to treatment, a parliamentary report has warned.
More than a third of women with PCOS waited over four years for a diagnosis, according to findings from the all-party parliamentary group.
After being diagnosed, 38 per cent said they were not offered any resources.
PCOS affects one in eight UK women of childbearing age.
The condition causes irregular periods, higher levels of the androgen hormone (which can trigger excess facial or body hair), and enlarged ovaries with fluid-filled sacs.
The report was based on patient surveys, oral evidence sessions and freedom of information requests to all 42 integrated care boards in England.
Only three per cent of patients felt supported by their healthcare providers. Almost a third reported feeling dismissed or not taken seriously.
Michelle Welsh is Labour MP for Sherwood Forest and chair of the APPG on PCOS.
She said: “PCOS affects one in eight women and those assigned female at birth, yet for too long it has been sidelined in policy, overlooked in funding, and misunderstood in practice.
“This report sets out a clear and urgent case for reform. If we are serious about improving women’s health, we must act now to break the cycle.”
The inquiry also revealed inequalities.
Women from Black and Asian backgrounds were up to 2.5 times more likely to be diagnosed with PCOS.
Those from ethnic minority groups more often had severe symptoms, including insulin resistance, a condition where the body struggles to use insulin properly.
Dr Itunu Johnson-Sogbetun, GP and founder of the Royal College of GPs’ women’s health special interest group, said the report reflected “what many of us with PCOS already know from lived experience: care is fragmented, diagnosis is delayed, and long-term risks are too often ignored.”
“PCOS is a multisystem condition, yet the NHS frequently treats it narrowly as a fertility or gynaecological issue.
“The report rightly highlights the postcode lottery of care, the lack of national pathways, and the absence of coordinated support for the metabolic, cardiovascular, and psychological complications that come with PCOS.”
The study also highlighted that the absence of Nice primary care guidance for PCOS had created a postcode lottery for patients, with variations in care across regions of the UK.
As a result, diagnosis often depends on individual clinician judgment, which can result in inconsistent and uncertain care.
Rachel Morman, chair of the charity Verity, said: “While this inquiry is about PCOS, it really is a barometer for how we value and prioritise women’s health across the entire system.
“For a condition affecting millions across the UK, with a significant cost burden to the NHS when not managed proactively in integrated care settings, this level of neglect is unacceptable.
“We welcome the report and its recommendations, and stand ready to work with the government to deliver the change that is so urgently needed.”
Wellness
WHO launches AI tool for reproductive health information

The World Health Organization (WHO) has launched an AI tool in beta to help policymakers, experts and healthcare professionals access sexual and reproductive health information faster.
Called ChatHRP, the tool was created by WHO’s Human Reproduction Programme and draws only on verified research and guidance collected by HRP and WHO.
It uses natural language processing and retrieval-augmented generation to produce referenced content and cut the time spent searching through documents across different platforms and databases.
WHO said ChatHRP also has multilingual capabilities and low-bandwidth functionality to support use in a wide range of settings.
The beta-testing phase is aimed at a broad professional audience, including policymakers, healthcare workers, researchers and civil society groups.
WHO said the tool can help users quickly access up-to-date evidence, find sources for academic work and verify information on sexual and reproductive health and rights.
Examples of questions it can answer include the latest violence against women data in Oceania for women aged 15 to 49, recommendations on managing diabetes during pregnancy, and whether PrEP and contraception can be used at the same time. PrEP is medicine used to reduce the risk of getting HIV.
WHO added that the system will be updated regularly as new HRP materials are published and includes a feedback loop so users can flag gaps in the information provided.
The launch comes amid wider concern about misinformation in sexual and reproductive health.
A 2025 scoping review found that misinformation in digital spaces is a systemic issue that can undermine human rights, reinforce discriminatory social norms and exclude marginalised voices.
The review also said misinformation can affect health systems by shaping provider knowledge and practice, disrupting service delivery and creating barriers to equitable care.
WHO said ChatHRP is intended to give users streamlined access to reliable information as a counter to “algorithms, opinions, or misinformation”.
Diagnosis
AI maps how reproductive organs age differently during menopause
Pregnancy
Early miscarriage care could prevent 10,000 pregnancy losses a year, study finds
Entrepreneur2 weeks agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
News1 week agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Fertility3 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Menopause3 weeks agoMore research needed to understand link between brain fog and menopause, expert says
Mental health2 weeks agoLifting weights shows mental health and cognitive benefits in older women, study finds
News4 weeks agoSelf-employment linked to better cardiovascular health outcomes in Hispanic women
Fertility3 weeks agoFlora Fertility closes US$5m seed round
News2 weeks agoResistance training has preventative effects in menopause, study finds


















4 Comments